Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseases
Authors
Gleda Hermansky
Emily Gilbertson
Jon Therriault
Jennifer L. Gardell (ORCID: https://orcid.org/0000-0002-2397-3468)
Lisa Bogatzki
Alex Chen (ORCID: https://orcid.org/0000-0002-0870-2723)
Monica Childs
Courtney A. Crane
Nadine Morgan (ORCID: https://orcid.org/0000-0001-7705-6043)
Meghan Maurer
Catherine J. McMahan (ORCID: https://orcid.org/0000-0003-1767-6325)
Daniel R. Boster
Susan Julien
Minh N. Pham (ORCID: https://orcid.org/0000-0002-2357-7721)
Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseases
Gleda Hermansky, Emily Gilbertson, Jon Therriault, Jennifer L. Gardell et al.
Citations
6 citations
Journal
Frontiers in Immunology
Topics
Immune Cell Function and Interaction
Field-Weighted Citation Impact (FWCI)
1.44
article
Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseases
Gleda Hermansky, Emily Gilbertson, Jon Therriault, Jennifer L. Gardell, Lisa Bogatzki, Alex Chen, Monica Childs, Courtney A. Crane, Nadine Morgan, Meghan Maurer, Catherine J. McMahan, Daniel R. Boster, Susan Julien, Minh N. Pham, Justin Bowser, Brent Meengs, Phoenicia Quach, Kristine M. Swiderek, Daniel T. Patton, Cong Tan, Kaelen Encarnacion